Cargando…

Dutcher bodies in an IgA‐myeloma patient harbouring the FGFR3/IGH fusion

Detalles Bibliográficos
Autores principales:	Manabe, Masahiro, Sogabe, Nobuhiro, Nanno, Satoru, Hagiwara, Yuuji, Asada, Reiko, Koh, Ki‐Ryang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Haematology Images
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188451/ https://www.ncbi.nlm.nih.gov/pubmed/37206264 http://dx.doi.org/10.1002/jha2.657

Ejemplares similares

A rare der(10)t(X;10)(p11.2;p11.2) in an elderly patient with therapy‐related acute myelomonocytic leukemia
por: Manabe, Masahiro, et al.
Publicado: (2021)

Dutcher bodies as a diagnostic key to POEMS syndrome
por: Matsuda, Ikuo, et al.
Publicado: (2023)

Co‐occurrence of JAK2 V617F‐mutated essential thrombocythemia and chronic lymphocytic leukemia harboring der(8;17)(q10;q10)
por: Manabe, Masahiro, et al.
Publicado: (2022)

A Rare t(5;11)(q35;q13) Translocation in an Elderly Patient With Acute Myeloid Leukemia With Maturation: A Case Report
por: Manabe, Masahiro, et al.
Publicado: (2018)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Follicular lymphoma with prominent Dutcher body formation after liver transplantation
por: Sung, You-Na, et al.
Publicado: (2019)

Russell body gastritis with Dutcher bodies evaluated using magnification endoscopy
por: Yorita, Kenji, et al.
Publicado: (2017)

IgG kappa multiple myeloma with isolated central nervous system relapse
por: Xu, Ke, et al.
Publicado: (2022)

Lymphoplasmacytic variant of multiple myeloma
por: Johansen, Silje, et al.
Publicado: (2022)

Myeloma‐induced leucocytoclastic vasculitis
por: De Abrew, Kanchana, et al.
Publicado: (2020)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Acquired platelet dysfunction in newly diagnosed myeloma
por: Mortimer, Joshua, et al.
Publicado: (2021)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder
por: Claushuis, Theodora A.M., et al.
Publicado: (2022)

Asymptomatic leishmaniasis in a patient with relapsed multiple myeloma
por: Rubio, Lucia, et al.
Publicado: (2021)

Lymphoid morphology, hyperviscosity and extensive immunoglobulin deposits in myeloma
por: Sehgal, Tushar, et al.
Publicado: (2022)

Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study
por: Royle, Kara‐Louise, et al.
Publicado: (2018)

A case of multiple myeloma with plasma cell cannibalism and cytophagocytosis
por: Varghese, Julia, et al.
Publicado: (2021)

Giant multinucleated plasma cells in relapsed plasma cell myeloma
por: Ghattas, Sylvia, et al.
Publicado: (2020)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Gastric involvement: A rare extramedullary location of multiple myeloma
por: Pedrosa, Cláudia, et al.
Publicado: (2020)

Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
por: Liu, Yang, et al.
Publicado: (2013)

Multiple myeloma with G‐CSF production mimicking chronic neutrophilic leukemia
por: Ureshino, Hiroshi, et al.
Publicado: (2021)

Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma
por: Okawa, Yutaka, et al.
Publicado: (2008)

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
por: Chen, Christine, et al.
Publicado: (2009)

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study
por: Jagannath, Sundar, et al.
Publicado: (2018)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

Seborrheic keratosis (Leser‐Trélat sign) in multiple myeloma signalling disease progression
por: Jenkins, Christopher, et al.
Publicado: (2020)

Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma
por: Álamo Moreno, José R., et al.
Publicado: (2023)

A case of multiple myeloma with AL amyloidosis showing giant Russel bodies
por: Mcphaden, Heather, et al.
Publicado: (2023)

Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma
por: Richardson, Paul G., et al.
Publicado: (2018)

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study
por: Yimer, Habte, et al.
Publicado: (2019)

A case of multiple myeloma with markedly straight lines or curved deep groove nuclei
por: He, Chang, et al.
Publicado: (2021)

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
por: Watanabe, Takashi, et al.
Publicado: (2016)

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
por: Levin, Nancy, et al.
Publicado: (2016)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
por: Richardson, Paul G., et al.
Publicado: (2018)

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
por: Kumar, Shaji, et al.
Publicado: (2017)

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma
por: Jakubowiak, Andrzej J., et al.
Publicado: (2019)

A rare case of relapsed multiple myeloma with aberrant T‐cell antigen expression and skin plasmacytomas
por: Lecat, Catherine S.Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0opktgljptktsm1ji2gjtbarv